ANI Pharmaceuticals
ANIP
ANIP
190 hedge funds and large institutions have $664M invested in ANI Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 71 increasing their positions, 64 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $704M → $664M (-$39.8M)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
26% less call options, than puts
Call options by funds: $4.7M | Put options by funds: $6.33M
Holders
190
Holding in Top 10
2
Calls
$4.7M
Puts
$6.33M
Top Buyers
| 1 | +$13M | |
| 2 | +$7.93M | |
| 3 | +$7.04M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$7.03M |
| 5 |
Man Group
London,
United Kingdom
|
+$6.19M |
Top Sellers
| 1 | -$8.17M | |
| 2 | -$3.99M | |
| 3 | -$3.87M | |
| 4 |
First Manhattan
New York
|
-$3.02M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.88M |